Stefan Suciu

2PUBLICATIONS
13CO-AUTHORS
Other education not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 25, 2021
Reply to E. Hindié.

Alexander M M Eggermont, Christian U Blank, Mario Mandala

|Sep 18, 2020
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.

Alexander M M Eggermont, Christian U Blank, Mario Mandala

Pageof 1

Frequent Collaborators

2 joint publications

Andrey Meshcheryakov

2 joint publications

James Larkin

2 joint publications

Paolo A Ascierto

2 joint publications

Dirk Schadendorf